How do I buy Atara Biotherapeutics (ATRA) stock?

You can purchase shares of Atara Biotherapeutics (NASDAQ:ATRA) through any online brokerage.View our list of the best stock brokerages

Who are Atara Biotherapeutics (ATRA) competitors?

Other companies in Atara Biotherapeutics’s space includes: Galecto Inc (NASDAQ:GLTO), Outlook Therapeutics Inc (NASDAQ:OTLK), Kyntra Bio Inc (NASDAQ:KYNB), Skye Bioscience Inc (NASDAQ:SKYE) and Estrella Immunopharma Inc (NASDAQ:ESLA).

What is the forecast, or price target, for Atara Biotherapeutics (ATRA) stock?

Atara Biotherapeutics has a consensus price target of $14.59.

What is the current price for Atara Biotherapeutics (ATRA)?

The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $5.16 last updated January 27, 2026 at 8:25 AM EST.

Does Atara Biotherapeutics (ATRA) pay a dividend?

There are no upcoming dividends for Atara Biotherapeutics.

When is Atara Biotherapeutics (NASDAQ:ATRA) reporting earnings?

Atara Biotherapeutics does not have any upcoming earnings scheduled.

Is Atara Biotherapeutics (ATRA) going to split?

There is no upcoming split for Atara Biotherapeutics.

What sector and industry does Atara Biotherapeutics (ATRA) operate in?

Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Atara Biotherapeutics (ATRA) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and man...

Comments